Primary Site >> Colorectal Cancer

Gene >> POC1A

  • 2015
Ref: The SOFT trial: a Phase III study of the dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine S-1 and oxaliplatin (SOX) plus bevacizumab as first-line chemotherapy for metastatic colorectal cancer.
PMID: 25963425